Cortisol levels are influenced by sedation in the acute phase after subarachnoid haemorrhage

Acta Anaesthesiologica Scandinavica

Volumn 57, Issue 4, 2013, Pages 452-460

  Lindgren, C ^a   Dahlqvist, P ^a   Lindvall, P ^a   Nilsson, L ^b   Koskinen, L O ^a   Naredi, S ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; HYDROCORTISONE; MIDAZOLAM; NIMODIPINE; PROPOFOL; THIOPENTAL; TRANSCORTIN;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; ISCHEMIA; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALIVA LEVEL; SEDATION; SUBARACHNOID HEMORRHAGE;

ADRENAL INSUFFICIENCY; ADULT; AGED; AGED, 80 AND OVER; CRITICAL ILLNESS; FEMALE; HUMANS; HYDROCORTISONE; HYPNOTICS AND SEDATIVES; LOGISTIC MODELS; MALE; MIDDLE AGED; SALIVA; SUBARACHNOID HEMORRHAGE; TRANSCORTIN;

EID: 84876296423     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12014     Document Type: Article

References (39)

1. Macmillan CS, Grant IS, Andrews PJ. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management? Intensive Care Med 2002; 28: 1012-23.
2. Kwon YS, Suh GY, Jeon K, Park SY, Lim SY, Koh WJ, Chung MP, Kim H, Kwon OJ. Serum cytokines and critical illness-related corticosteroid insufficiency. Intensive Care Med 2010; 36: 1845-51.
3. Naredi S, Lambert G, Eden E, Zall S, Runnerstam M, Ryden-hag B, Friberg P. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 2000; 31: 901-6.
4. Beishuizen A, Thijs LG. The immunoneuroendocrine axis in critical illness: beneficial adaptation or neuroendocrine exhaustion? Curr Opin Crit Care 2004; 10: 461-7.
5. Venkataraman S, Munoz R, Candido C, Witchel SF. The hypothalamic- pituitary-adrenal axis in critical illness. Rev Endocr Metab Disord 2007; 8: 365-73.
6. Tanriverdi F, Dagli AT, Karaca Z, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F. High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: a prospective investigation of anterior pituitary function in the acute phase and 12 months after the event. Clin Endocrinol (Oxf) 2007; 67: 931-7.
7. Dimopoulou I, Kouyialis AT, Tzanella M, Armaganidis A, Thalassinos N, Sakas DE, Tsagarakis S. High incidence of neuroendocrine dysfunction in long-term survivors of aneu-rysmal subarachnoid hemorrhage. Stroke 2004; 35: 2884-9.
8. Kreitschmann-Andermahr I, Hoff C, Saller B, Niggemeier S, Pruemper S, Hutter BO, Rohde V, Gressner A, Matern S, Gilsbach JM. Prevalence of pituitary deficiency in patients after aneurysmal subarachnoid hemorrhage. J Clin Endocri-nol Metab 2004; 89: 4986-92.
9. Weant KA, Sasaki-Adams D, Dziedzic K, Ewend M. Acute relative adrenal insufficiency after aneurysmal subarach-noid hemorrhage. Neurosurgery 2008; 63: 645-9; discussion 49-50.
10. Bendel S, Koivisto T, Ruokonen E, Rinne J, Romppanen J, Vauhkonen I, Kiviniemi V, Uusaro A. Pituitary-adrenal function in patients with acute subarachnoid haemorrhage: a prospective cohort study. Crit Care 2008; 12: R126.
11. Poll EM, Bostrom A, Burgel U, Reinges MH, Hans FJ, Gilsbach JM, Kreitschmann-Andermahr I. Cortisol dynamics in the acute phase of aneurysmal subarachnoid hemorrhage: associations with disease severity and outcome. J Neuro-trauma 2010; 27: 189-95.
12. Zetterling M, Engstrom BE, Hallberg L, Hillered L, Enblad P, Karlsson T, Ronne Engstrom E. Cortisol and adrenocortico-tropic hormone dynamics in the acute phase of subarach-noid haemorrhage. Br J Neurosurg 2011; 25: 684-92.
13. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivo-gel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J. Hydro-cortisone therapy for patients with septic shock. N Engl J Med 2008; 358: 111-24.
14. Marik PE. Critical illness-related corticosteroid insufficiency. Chest 2009; 135: 181-93.
15. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, Tsa-garakis S, Singer M, Chrousos GP, Zaloga G, Bokhari F, Vogeser M. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36: 1937-49.
16. Venkatesh B, Cohen J. Adrenocortical (dys)function in septic shock-a sick euadrenal state. Best Pract Res Clin Endocrinol Metab 2011; 25: 719-33.
17. Sorrells SF, Caso JR, Munhoz CD, Sapolsky RM. The stressed CNS: when glucocorticoids aggravate inflammation. Neuron 2009; 64: 33-9.
18. Britt RC, Devine A, Swallen KC, Weireter LJ, Collins JN, Cole FJ, Britt LD. Corticosteroid use in the intensive care unit: at what cost? Arch Surg 2006; 141: 145-9; discussion 49.
19. Chen X, Zhang KL, Yang SY, Dong JF, Zhang JN. Glucocor-ticoids aggravate retrograde memory deficiency associated with traumatic brain injury in rats. J Neurotrauma 2009; 26: 253-60.
20. Smith-Swintosky VL, Pettigrew LC, Sapolsky RM, Phares C, Craddock SD, Brooke SM, Mattson MP. Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures. J Cereb Blood Flow Metab 1996; 16: 585-98.
21. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350: 1629-38.
22. Coolens JL, Van Baelen H, Heyns W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem 1987; 26: 197-202.
23. Arafah BM, Nishiyama FJ, Tlaygeh H, Hejal R. Measurement of salivary cortisol concentration in the assessment of adrenal function in critically ill subjects: a surrogate marker of the circulating free cortisol. J Clin Endocrinol Metab 2007; 92: 2965-71.
24. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968; 28: 14-20.
25. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasos-pasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6: 1-9.
26. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-10.
27. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1: 480-4.
28. Cohan P, Wang C, McArthur DL, Cook SW, Dusick JR, Armin B, Swerdloff R, Vespa P, Muizelaar JP, Cryer HG, Christenson PD, Kelly DF. Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit Care Med 2005; 33: 2358-66.
29. Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E. Hypopituitarism. Lancet 2007; 369: 1461-70.
30. Bendel S, Karlsson S, Pettila V, Loisa P, Varpula M, Ruoko-nen E. Free cortisol in sepsis and septic shock. Anesth Analg 2008; 106: 1813-9.
31. Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, Boudou P. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006; 174: 1319-26.
32. Skoglund K, Enblad P, Hillered L, Marklund N. The neurological wake-up test increases stress hormone levels in patients with severe traumatic brain injury. Crit Care Med 2012; 40: 216-22.
33. Cuthbertson BH, Sprung CL, Annane D, Chevret S, Garfield M, Goodman S, Laterre PF, Vincent JL, Freivogel K, Reinhart K, Singer M, Payen D, Weiss YG. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 2009; 35: 1868-76.
34. Colameco S, Coren JS. Opioid-induced endocrinopathy. J Am Osteopath Assoc 2009; 109: 20-5.
35. Shapiro JM, Westphal LM, White PF, Sladen RN, Rosenthal MH. Midazolam infusion for sedation in the intensive care unit: effect on adrenal function. Anesthesiology 1986; 64: 394-8.
36. Fragen RJ, Weiss HW, Molteni A. The effect of propofol on adrenocortical steroidogenesis: a comparative study with etomidate and thiopental. Anesthesiology 1987; 66: 839-42.
37. Mistraletti G, Donatelli F, Carli F. Metabolic and endocrine effects of sedative agents. Curr Opin Crit Care 2005; 11: 312-7.
38. Parker CR Jr, Slayden SM, Azziz R, Crabbe SL, Hines GA, Boots LR, Bae S. Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. J Clin Endocrinol Metab 2000; 85: 48-54.
39. Wilkinson CW, Petrie EC, Murray SR, Colasurdo EA, Raskind MA, Peskind ER. Human glucocorticoid feedback inhibition is reduced in older individuals: evening study. J Clin Endocrinol Metab 2001; 86: 545-50.